SubsidieMeestersMULTIMODE NONLINEAR FIBER BASED ENDOSCOPIC IMAGING AND TREATMENT
MULTISCOPE aims to revolutionize optical diagnostics and therapy by developing a dual-function endoscopic device for real-time optical biopsy and cold atmospheric plasma treatment in gastrointestinal care.
Projectdetails
Introduction
MULTISCOPE introduces a revolutionary photonic technology that represents a significant advancement in the field of optical diagnostics and therapy. Our approach is based on cutting-edge research into pulse propagation within nonlinear complex structures.
Device Development
We are developing an endoscopic device that seamlessly combines optical biopsy and cold atmospheric plasma treatment. This dual-functionality device harnesses the spatiotemporal control of powerful light in multimode fibers, which were previously overlooked due to concerns about excessive light destructuring.
Technological Advancements
We leverage the remarkable progress in the development of the latest optical fibers and in the precise control of light within multimode guides, enabling us to harness the power of plasma, the fourth state of matter.
Focus Areas
Initially, our focus is on gastrointestinal (GI) endoscopy, but our ultimate goal is to extend this technology to all areas of medical diagnostics where there is a pressing need for reliable tools for "optical biopsy" and "instant pathology." These tools are crucial for real-time diagnosis but have not yet reached the level of trustworthiness required for widespread use.
Importance of Endoscopy
Endoscopy is a vital tool for diagnosing and treating GI disorders, offering a safe and effective approach. However, the current standard of care still relies on histopathology for conclusive cancer diagnosis. This leads to significant delays in initiating treatment and incurs high costs.
Project Goals
Our project is set to transform this landscape by bringing to life the long-anticipated concept of real-time, in-vivo optical diagnosis, often referred to as "optical biopsy."
Integration of Technologies
Our groundbreaking approach seamlessly integrates endoscopic capabilities with cold atmospheric plasma therapy, which employs controlled plasma jets to precisely target and eliminate cancer cells by inducing cellular apoptosis.
Conclusion
By combining plasma therapy with optical biopsy, we not only provide real-time diagnosis but also offer immediate therapeutic intervention.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.863.733 |
| Totale projectbegroting | € 2.863.733 |
Tijdlijn
| Startdatum | 1-12-2024 |
| Einddatum | 30-11-2027 |
| Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZApenvoerder
- UNIVERSITE DE LIMOGES
- UNIVERSITA CATTOLICA DEL SACRO CUORE
- FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS
- Erbe Elektromedizin GmbH
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Hybrid endoscope for esophageal in vivo histology and histochemistryESOHISTO aims to revolutionize GI cancer diagnosis through innovative endoscopic technologies that enable real-time 3D imaging of diseased tissues, enhancing early detection and treatment. | EIC Pathfinder | € 3.046.127 | 2025 | Details |
ADAPTIVE OPTICAL METASURFACES FOR REAL-TIME, LABEL-FREE AND NON-DESTRUCTIVE 7D DIGITAL PATHOLOGYOPTIPATH aims to revolutionize tissue diagnosis by providing real-time, non-destructive 3D imaging using advanced optical technologies and machine learning to enhance accuracy and reduce variability. | EIC Pathfinder | € 3.276.577 | 2025 | Details |
A minimally Invasive surgical platform aGainst paNcreatIc and biliary Tract cancErs using cold atmospheric PLASMAThis project aims to develop a novel cold atmospheric pressure plasma system for minimally invasive treatment of pancreatic and biliary tract cancers, integrating advanced modeling and in-vivo testing. | EIC Pathfinder | € 2.792.500 | 2024 | Details |
On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technologyDISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI. | EIC Pathfinder | € 3.018.312 | 2022 | Details |
Live Cell Spectroscopy Analysis for Personalised Particle Radiation Therapy of Metastatic Bone CancerBoneOscopy aims to revolutionize metastatic bone cancer treatment by enabling daily monitoring during particle radiotherapy, enhancing personalized care and treatment efficacy. | EIC Pathfinder | € 3.069.321 | 2025 | Details |
Hybrid endoscope for esophageal in vivo histology and histochemistry
ESOHISTO aims to revolutionize GI cancer diagnosis through innovative endoscopic technologies that enable real-time 3D imaging of diseased tissues, enhancing early detection and treatment.
ADAPTIVE OPTICAL METASURFACES FOR REAL-TIME, LABEL-FREE AND NON-DESTRUCTIVE 7D DIGITAL PATHOLOGY
OPTIPATH aims to revolutionize tissue diagnosis by providing real-time, non-destructive 3D imaging using advanced optical technologies and machine learning to enhance accuracy and reduce variability.
A minimally Invasive surgical platform aGainst paNcreatIc and biliary Tract cancErs using cold atmospheric PLASMA
This project aims to develop a novel cold atmospheric pressure plasma system for minimally invasive treatment of pancreatic and biliary tract cancers, integrating advanced modeling and in-vivo testing.
On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technology
DISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI.
Live Cell Spectroscopy Analysis for Personalised Particle Radiation Therapy of Metastatic Bone Cancer
BoneOscopy aims to revolutionize metastatic bone cancer treatment by enabling daily monitoring during particle radiotherapy, enhancing personalized care and treatment efficacy.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
In vivo Immunofluorescence-Optical Coherence TomographyDevelop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease. | ERC Advanced... | € 2.500.000 | 2025 | Details |
Real-time multi-spectral imaging for accurate detection of cancerous tissue in endoscopic surgeryThericon is developing an rMSI platform to enhance endoscopic cancer surgery by providing multi-parametric imaging for better tissue differentiation and reducing cancer recurrence, seeking funding for market launch in 2024. | EIC Accelerator | € 2.500.000 | 2022 | Details |
FunctIonal optoacousticS for imaging Early onsEt of Gut inflammationThis project aims to develop functionalized contrast agents for multispectral optoacoustic tomography to enable non-invasive early detection of gastrointestinal inflammation. | ERC Starting... | € 1.453.730 | 2023 | Details |
Multi-sensor Eversion Robot Towards Intelligent Endoscopic Diagnosis and TherapyEndoTheranostics aims to revolutionize colorectal cancer screening and treatment through a robotic system that enables painless preparation, real-time polyp detection, and effective removal using advanced imaging and tools. | ERC Synergy ... | € 7.616.426 | 2024 | Details |
Method for Integrated All-Optical Biological Analysis at ScaleDeveloping an all-optical platform for precise optogenetic probing and automated data analysis to enhance research in neuroscience, developmental biology, and cancer. | ERC Proof of... | € 150.000 | 2024 | Details |
In vivo Immunofluorescence-Optical Coherence Tomography
Develop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease.
Real-time multi-spectral imaging for accurate detection of cancerous tissue in endoscopic surgery
Thericon is developing an rMSI platform to enhance endoscopic cancer surgery by providing multi-parametric imaging for better tissue differentiation and reducing cancer recurrence, seeking funding for market launch in 2024.
FunctIonal optoacousticS for imaging Early onsEt of Gut inflammation
This project aims to develop functionalized contrast agents for multispectral optoacoustic tomography to enable non-invasive early detection of gastrointestinal inflammation.
Multi-sensor Eversion Robot Towards Intelligent Endoscopic Diagnosis and Therapy
EndoTheranostics aims to revolutionize colorectal cancer screening and treatment through a robotic system that enables painless preparation, real-time polyp detection, and effective removal using advanced imaging and tools.
Method for Integrated All-Optical Biological Analysis at Scale
Developing an all-optical platform for precise optogenetic probing and automated data analysis to enhance research in neuroscience, developmental biology, and cancer.